sirolimus

Product NDC
68382-351
11-digit product format
683820351
Labeler code
68382
Product ID
68382-351_f54f3f24-5d0f-44a1-a4ca-03950954826f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
sirolimus
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Zydus Pharmaceuticals USA Inc.
Application
ANDA201676
Marketing category
ANDA
Marketing start
2023-02-16
Substance
SIROLIMUS
Active strength
1 mg/1
Pharmacologic classes
Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
W36ZG6FT64SIROLIMUS53123-88-9SIROLIMUS

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
68382-351-0168382035101100 TABLET, FILM COATED in 1 BOTTLE (68382-351-01) 2023-02-16NoNoHistorical
68382-351-776838203517710 BLISTER PACK in 1 CARTON (68382-351-77) / 10 TABLET, FILM COATED in 1 BLISTER PACK (68382-351-30) 10 blister pack2023-02-16NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
sirolimusZydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited2023-07-20HUMAN PRESCRIPTION DRUG LABEL16